PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Update

Posted by on May 18th, 2026

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,774 shares, an increase of ∞ from the April 15th total of 0 shares. Based on an average trading volume of 984,095 shares, the short-interest ratio is currently 0.0 days.

PharmaTher Stock Down 1.2%

PHRRF traded down $0.00 during trading hours on Monday, reaching $0.05. The company’s stock had a trading volume of 136,055 shares, compared to its average volume of 183,213. PharmaTher has a 52 week low of $0.04 and a 52 week high of $0.55. The company’s 50-day moving average is $0.05 and its 200-day moving average is $0.07.

PharmaTher Company Profile

(Get Free Report)

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.

Featured Articles

Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.